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The present study. Epinephrine is an established pharma-
cologic agent fo use during resuscitation from ventricular
fibrillation (1).
Its value has been proved in experimental
animals (2), and it has been accepted and used in the clinical
setting for more than a decade . Its potent alpha-adrenergic
vasoeonstrictive effects, which maintain blood pressure and
coronary perfusion pressure, have been demonstrated to be
its primary mechanism for benefit (3).
In this issue of the
Journal, Midei et al . (4) present experimental data suggesting
that the potent beta-adrenergic effects of epinephrine are
potentially deleterious because they may result in increased
oxygen consumption both by exerting a direct metabolic
effect and by increasing wall tension during fibrillation . The
increased contraction strength of fibrillation might also re-
duce myocardial perfusion . Overall, this study was designed
to evaluate whether this increase in myocardial oxygen
consumption at the low perfusion pressures characteristic of
cardiopulmonary resuscitation was disadvantageous
. Epi-
nephrine was compared with phenylephrine, which is a more
pure alpha-vasoconstrictor, although there is some inotropic
stimulation of alpha-receptors in the myocardium .
Epinephrine versus phenylephrine
. Interpretation of the
results was simplified by use of the isolated perfused canine
ventricles in which perfusion pressure can be controlled
.
Unfortunately this preparation is also far removed from the
intact circulation, and therefore the study findings must be
interpreted accordingly. In this study coronary blood flow
and oxygen consumption levels were highest for epineph-
rine, intermediate for phenylephrine and lowest for no
infusion of drug. Left ventricular function was measured by
the slope of the end-systolic pressure-volume relation
. With
epinephrine this slope was only 72%
of the baseline value
I0min after restoration of sinus rhythm and 100 mm Hg
perfusion pressure . In contrast, in the phenylephrine-treated
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group the slope increased to 143% of the baseline value and
in the control group it was 82% of baseline . End-diastolic
pressure was not different at 10 min after defibrillation in any
of the groups.
Because this study was performed in the isolated per-
fused heart, the peripheral alpha-constrictive effects of these
drug doses could not be compared . The doses of epinephrine
(5 ug/min) and phenylephrine (50
µg/min),
which were
infused directly into the coronary perfusion circuit, are high
doses . As indicated in the protocol, a 10-fold higher dose of
phenylephrine was chosen for the study than the dose that
usually produced a full vasoconstrictive response .
i
he most strikingfinding of
this study was the increase in
rentricular function seen in the phenylephrine-treated
group . This may well
be
related to the high dose used and the
presence of some myocardial alpha-receptors . Because the
dose of phenylephrine caused only a small increase in
oxygen consumption, it was suggested that this agent could
conceivably be better than epinephrine. which increased
myocardial oxygen demand more . However, the reduction
in contractility with epinephrine seen 10 min after defibril-
lation and restoration of blood flow was not statistically less
than in the control group . Thus, although one could demon-
strate a higher oxygen consumption with epinephrine, one
could not demonstrate a statistically significant reduction in
postresuscitation contractility in comparison with the con-
trol group .
Conclusions. Thus, this interesting study should not
prompt us to eliminate epinephrine as a drug for the treat-
ment of cardiopulmonary resuscitation ; experience has sug-
gested its efficacy in the clinical setting . This study does
indicate, however, that phenylephrine has some attractive
features that should be further investigated . These include
the production of peripheral vasoconstriction (so essential to
the resuscitation process)
. a lesser rise in oxygen consump-
tion and a small but demonstrable increase in contractility,
which was a statistically better outcome than that afforded
by infusion of epinephrine or of no drug, both of which
resulted in diminished contractility . Studies in intact animals
must be carefully performed before one can confidently
recommend phenylephrine as a better drug than epinephrine
.
It should be noted that Schiein et al
. (5) compared epineph-
rine with phenylephrine during cardiopulmonary resuscita-
tion in dogs and found no differences in coronary or cerebral
flow
or resuscitation. Overall, however, it is clear that
phenylephrine has some theoretic advantages over epineph-
rine and does deserve additional study .
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